The Technical Analyst
Select Language :
Zylox-Tonbridge Medical [2190.HK]

Exchange: HKSE Sector: Healthcare Industry: Medical Devices

Zylox-Tonbridge Medical Price, Forecast, Insider, Ratings, Fundamentals & Signals

Zylox-Tonbridge Medical is listed at the  Exchange

1.71% HKD10.68

America/New_York / 3 mai 2024 @ 03:58


Zylox-Tonbridge Medical: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 3 377.70 mill
EPS: -0.260
P/E: -41.08
Earnings Date: Jun 07, 2024
SharesOutstanding: 316.26 mill
Avg Daily Volume: 0.219 mill
RATING 2024-05-03
C
Sell
RATINGS
Rating CashFlow: Sell
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Strong Sell
Price To Book: Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profitn/an/an/a
Ebitn/an/an/a
Asset n/an/an/a
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -41.08 | sector: PE 34.76
PE RATIO: COMPANY / INDUSTRY
-0.51x
Company: PE -41.08 | industry: PE 81.28
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

HKD 10.30 - 11.06

( +/- 3.60%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - HKD10.68
Forecast 2: 16:00 - HKD10.68
Forecast 3: 16:00 - HKD10.68
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price HKD10.68 (1.71% )
Volume 0.119 mill
Avg. Vol. 0.219 mill
% of Avg. Vol 54.00 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Zylox-Tonbridge Medical Technology Co., Ltd.

Last 12 Months

Last 12 months chart data with high, low, open and close for Zylox-Tonbridge Medical Technology Co., Ltd.

RSI

Last 10 Buy & Sell Signals For 2190.HK

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Zylox-Tonbridge Medical Technology Co., Ltd.

2190.HK

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices China and internationally. It primarily offers ThromBite Clot Retriever Device, which is intended to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke; Balloon Guiding Catheter; Cylone Aspiration Catheter; ZENFLEX Pro Peripheral Drug-eluting Stent System for complex lesions and restenotic symptomatic lesions; ZENFlex Peripheral Stent System to deliver a self-expanding stent to the iliac artery, superficial femoral arteries, and/or proximal popliteal arteries through a 6F delivery system; and drug-coated percutaneous transluminal angioplasty (PTA) Balloon Catheters that are indicated for PTA of stenosis or occlusion lesions in iliac, femoral, or popliteal arteries. The company also provides Ton-Bridge extra soft coils for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities, such as arteriovenous malformations and arteriovenous fistulae; microcatheter for coiling; distal access catheter; glycine micro catheter for professional physician to selectively inject or input control medium and/or embolic materials, and/or appropriate devices; Intracranial PTA balloon catheter; vascular snare; and snare retrieval kit for IVC filter. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Zhejiang, the People's Republic of China.

Last 10 Buy Signals

Date Signal @
UALMay 3 - 10:38$51.68
STSOLUSDMay 3 - 10:36167.19
PSGUSDMay 3 - 10:354.79
ZLUSXMay 3 - 10:2842.77
^RUTMay 3 - 10:23PTS2 036.36
VRTXMay 3 - 10:36$398.20
PROMUSDMay 3 - 10:34$10.42
^SP500-35May 3 - 10:351 632.64
AALMay 3 - 10:35$13.82
PODDMay 3 - 10:34$176.82

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.